Dennis Ding
Stock Analyst at Jefferies
(0)
# 4854
Out of 5,333 analysts
18
Total ratings
14.29%
Success rate
-26.05%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CRNX Crinetics Pharmaceuticals | Upgrades: Buy | 55 | 30.7 | 79.15% | 1 | Jan 22, 2025 | |
IKT Inhibikase Therapeutics | Initiates Coverage On: Buy | 8 | 2 | 300% | 1 | Nov 8, 2024 | |
ASMB Assembly Biosciences | Upgrades: Buy | 2 35 | 12.18 | 187.36% | 1 | Sep 20, 2024 | |
FOLD Amicus Therapeutics | Initiates Coverage On: Buy | 18 | 6 | 200% | 1 | Sep 6, 2024 | |
ABUS Arbutus Biopharma | Maintains: Strong Buy | 5 7 | 3.23 | 116.72% | 2 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 8 6 | 4.32 | 38.89% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 1 | 0.1 | 400% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 648 | n/a | n/a | 1 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 35 22 | 70.27 | -68.69% | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 18.4 | 30.43% | 1 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 195 52 | n/a | n/a | 2 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 10.64 | -6.02% | 1 | Oct 26, 2021 |